|
"lu m c"的相關文件
顯示項目 16-25 / 235 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-02-10T06:29:51Z |
Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity
|
Wu, C-H; Hsieh, S-C; KO-JEN LI; Lu, M-C; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:28:29Z |
Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils
|
Hsieh, S C; Yu, H S; Cheng, S H; KO-JEN LI; Lu, M C; Wu, C H; Tsai, C Y; Yu, C L |
| 臺大學術典藏 |
2022-02-10T06:25:12Z |
Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics
|
Lu, M-C; Hsieh, S-C; Lai, N-S; KO-JEN LI; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:22:02Z |
Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus
|
Lu, M-C; Lai, N-S; KO-JEN LI; Hsieh, S-C; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:16:49Z |
Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus
|
Hsieh, S-C; Wu, T-H; Tsai, C-Y; KO-JEN LI; Lu, M-C; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T05:36:39Z |
Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus
|
Hsieh, S-C; Wu, T-H; Tsai, C-Y; KO-JEN LI; Lu, M-C; Wu, C-H; Yu, C-L |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal
|
Jean, S.-S.;Lu, M.-C.;Ho, M.-W.;Ko, W.-C.;Hsueh, P.-R.;Group, SMART Taiwan |
| 國立成功大學 |
2022 |
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstre
|
Jean, S.-S.;Ko, W.-C.;Lu, M.-C.;Lee, W.-S.;Hsueh, P.-R.;Program, on behalf of the SMART |
| 國立成功大學 |
2022 |
Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy
|
Yeh, T.-K.;Jean, S.-S.;Lee, Y.-L.;Lu, M.-C.;Ko, W.-C.;Lin, H.-J.;Liu, P.-Y.;Hsueh, P.-R. |
顯示項目 16-25 / 235 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
